The R&D 100 awards—called the “Oscars of Innovation”—recognize the 100 most technologically significant products introduced into the marketplace each year. Brookhaven Lab’s endeavors to transform breakthrough scientific discoveries into game-changing technology—including advances in x-ray imaging techniques, cancer detection, and energy catalysis—have resulted in many R&D 100 recognitions. Brookhaven continues its commitment to partnerships between cutting-edge basic science and commercial deployment to help meet energy challenges, strengthen national security, and stimulate the economy.
See how you can partner with us to create tomorrow’s award-winning innovations.
Brookhaven chemist Radoslav Adzic and his research team developed durable, high-performing, low-platinum electrocatalysts optimized for use in electric vehicle fuel cells.
Researchers at the National Synchrotron Light Source and Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO) developed the Maia x-ray microprobe detector system, capable of imaging everything from Rembrandt paintings to soil deposits 1,000 times faster than previous methods.
Collaborating with Hybridyne Imaging Technologies, Inc., Brookhaven scientists invented a compact gamma camera called ProxiScan, capable of detecting prostate cancer at an early stage and raising the chances of early diagnosis and treatment.
National Synchrotron Light Source scientists developed the Sagittal Focusing Laue Monochromator, the first device able to focus a large spread of high-energy x-rays to study physics, biology, and nanotechnology with superior beam intensity, higher image resolution, and greater efficiency.
Kansas State University and Yinnel Tech, Inc. collaborated with Brookhaven to create a highly efficient, low-cost portable radiation detector for homeland security applications, nuclear medical imaging, environmental monitoring and cleanup, galactic events studies, and nuclear-weapons safeguards.
Biophysicist F. William Studier developed a new process that simplifies the production of proteins in the T7 gene expression system (also patented at Brookhaven Lab), implemented worldwide by academic and industrial researchers using proteins as enzymes, diagnostics, vaccines, therapeutics and targets for developing pharmaceuticals.